While medical drug development increases steadily, ethical obligations within clinical trials play a greater role. Many patient groups seek to give trial participants a voice and ensure that pharmaceutical companies pay attention to their responsibility towards their patients.
Be the Partner enables sponsors to fulfill their ethical obligations easily by enabling them to inform patients about the drug as soon as the product comes to the market.
Patients who did not respond well to the investigational drug during the trial are protected from setbacks, and will clearly benefit from this information. But patients who did respond well will also have the opportunity to inform their doctor, and potentially take the drug again.
In a nutshell: direct patient engagement and communication derives value for both parties and makes clinical trials more transparent.